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Abstract 
Background: Glaucoma is a kind of lifelong disease characterized by irreversible optic 
nerve damage and visual field loss which lead to visual impairment and blindness. This 
ultimately limits person`s independence and compromises overall quality of life. 
Objective: to assess the quality of life and associated factors among patients with 
glaucoma attending University of Gondar Hospital, Northwest Ethiopia.  
Methods: Institution-based cross-sectional study was conducted from April –May 2015 
at University of Gondar Hospital. The sample size of this study was 307 patients with 
glaucoma. Consecutive patients who came to the hospital during the study period were 
included. Structured questionnaire was used for interviewing the study participants. A 
modified glaucoma quality of life -15 was used. Data was cleaned, coded and entered 
into EPI-INFO version 7 and was exported to SPSS version 20 for analysis. Logistic 
regression was used and association was interpreted using odds ratio and confidence 
interval .P-value < 0.05 was considered statistically significant in this study.  
Results: One hundred sixty two (52.8%) of the respondents had poor quality of life. 
Respondents age 40-70(AOR=3.51,95%CI:1.19-10.28) and ≥71 years old 
(AOR=3.72,95%CI:1.15-12.02),rural residence   (AOR=2.16,95%CI:1.10-4.22), married 
(AOR=2.27,95%CI:1.13-4.56), monthly income of < 400 EB (AOR=10.79,95%CI:3.36-
34.64), diagnosis time 1-5 years (AOR=2.57, 95%CI:1.29-5.15), moderately visually 
impaired (AOR=4.09,95%CI:2.02-8.34) and those with severe visual impairment  
(AOR=2.54,95%CI 1.01-6.39), moderate glaucoma (AOR= 4.09, 95%CI: 2.02-8.34), 
and severe  glaucoma (AOR= 2.88, 95%CI: 1.21-6.84) were found to be significantly 
associated with poor quality of life.   
 Conclusion: This study indicates that high proportion of patients with glaucoma have 
poor quality of life. Increasing age, rural residence, low monthly income, long time of 
diagnosis, increasing visual impairment and increasing glaucoma staging were 
significantly associated with poor quality of life. Establishing glaucoma screening 
program at community level for early detection and treatment, increasing income, giving 
special attention for rural community and elders are important factors for improving the 
quality of life of patients with glaucoma. 
Keywords: Glaucoma, Quality of life, GQOL-15.
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1. Introduction 
1.1. Statement of the problem  
Vision related quality of life (VRQOL) is defined as  a person’s satisfaction with their 
visual ability and how their vision impacts on their daily life(1). 
 
Over all QOL is compromised by glaucoma which represents a heterogeneous group of 
diseases that have in common characteristics form of damage to the optic nerve and 
visual field loss. The badness of Glaucoma is first affects mid periphery of visual field 
then central vision. This makes glaucoma patients tend to be asymptomatic until late in 
the disease(2). And it is believed that affects an individual quality of life negatively (3). 
According to the WHO, “Quality of life is defined as individuals’ perceptions of their 
position in life in the context of the culture and value systems in which they live and in 
relation to their goals, expectations, standards and concerns”. It is a broad concept 
affected in a complex way by the person’s physical health, psychological state and level 
of independence, social relationships, to most important features of their environment 
(4).  
Glaucoma patients  experience difficulty in recognizing faces, reading, watching 
television, noticing objects in their peripheral vision, adapting to different levels of 
lighting and  glaucoma patients are also  at a higher risk of falls and accidents(5). 
 
Besides to visual field loss and visual impairment, living with a chronic disease like 
glaucoma affects an individual QOL negatively by the diagnosis itself, cost and side 
effect of the drug, intolerance of the daily treatment and need of intensive and lifelong 
follow up (6).  
There are limited information from Ethiopia focusing on this study area , and thus this 
study may present as a baseline information on proportion of quality of life and 
associated factors of patients with glaucoma in Ethiopia in general and in particular for 
the study area. 
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1.2 Literature review 
  
Glaucoma is public health importance globally being the second leading cause of 
irreversible blindness(7).  
A systematic literature review study conducted on QOL among peripheral vision loss 
and central vision loss glaucoma and Age Related Macular Degeneration (ARMD) 
respectively revealed that both affects  general vision and treatment expectations 
domains, but glaucoma mostly affects mental aspects of QOL and un like glaucoma, 
ARMD affects physical aspect of QOL, in general ARMD affects patients QOL more 
than glaucoma (8).  
 
A retrospective study was conducted at four European countries (France, Denmark, 
Germany and United Kingdom) on late stage glaucoma patients revealed that visual 
acuity was positively correlated with QOL (9). 
 
A study  conducted in USA based on six vision-related activities (two visual function 
questions, and five physical functioning domains) those subjects who have severe 
visual field (VF) loss was associated with difficulty of daily living activities such as social 
activities, leisure, worrying about eyesight, of these  the most difficult are; day time 
driving in familiar places and noticing objects off to the side when walking(10). 
 
A  study done on impact of dry eye on daily life (QOL) in  patients with glaucoma who 
use and who are not use anti glaucoma medications in USA at the Miami Veterans 
Affairs, there is an association between number of medication with dry eye symptom  in 
turn dry eye symptoms has strong association with QOL(11, 12),also black race 
glaucoma patients has severe dry eye symptom and low QOL than white patients(12). 
 
A cross sectional  study also done in USA patients with bilateral glaucoma showed that 
reduced their QOL than patients without glaucoma and  those who had unilateral  
glaucoma were  reported that less difficulty on their activities of daily tasks as compared 
to those who had bilateral  glaucoma (13) 
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Another study also done in USA on aged patients with glaucoma whose ages are 
greater than or equal to 65 to assess factors of topical medication use and health 
related quality of life (HRQOL) showed that medication usage difficulty was strongly 
associated with low HRQOL than other factors: drug compliance, belief in benefit of 
medication use usage assistance and complexity of medication regimen (14). 
 
.To assess functional status and well-being in glaucoma patients who live in a 
developing country, Cross-sectional case control study was conducted in Brazil  
patients with glaucoma who live in developing country had low physical functioning, 
role-emotional, bodily pain, social functioning and mental health than control 
groups(15).  
 
Another  study was done in Brazil on Association between change in binocular Retinal 
nerve fiber layer loss (RNFL) thickness and change in visual function, after controlling 
confounding factors there is a strong association between QOL and RNFL loss  so 
degree of  RNFL loss are a good measurement scale  for level of QOL of the 
patient(16). 
 
In Brazil a cross sectional comparative study also done among glaucoma patients on 
impact of medical and surgical treatment on patients HRQOL, early glaucomatous 
patients  who under gone to surgical treatment had low QOL due to psychological 
burden, unlike moderate and advanced glaucoma patients who had similar QOL for 
both medical and surgical therapies(17).  
 
Cross sectional study was also done using NEI-VFQ (national eye institute –visual 
function questionnaire in Brazil on patients with glaucoma of different stages revealed 
that patients who attend private practice had better QOL than public health institution 
users (18). 
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Norwegians study showed that 80% of patients with glaucoma had negative effect on 
their QOL because of being glaucoma patient moreover younger and female patients 
were less satisfied than males on their life (19). 
A cross-sectional study conducted in Madrid, Spain in the relationship between visual 
function and the perceived quality of life in patients with glaucoma and ocular 
hypertension found moderate relationship between quality of life, visual acuity and 
visual field loss, so measuring quality of life is useful for management of patients with 
glaucoma (20). 
A  study done in two different sites of Sweden showed that glaucoma patients had low 
health related QOL than control groups, and it is associated due to reduced VA and VF 
and co morbidity of systemic cardiovascular and non vascular diseases as well, this 
study also stated that topical beta –blocker had no negative effect on their HRQOL(21). 
Japanese study showed that  the result of poor QOL for elderly patients with glaucoma 
is  due to loss of hope for future rather than the disease  symptom itself (22). 
Study conducted in China on relationship between visual impairment of glaucoma and 
quality of life, showed that visual impairment affects patient QOL negatively (23). 
A study  done in India dark adaptation and glare is the most problem for glaucoma 
patients (24).Another study also done in China showed that glaucoma patients have 
greater difficulty on activities which involve:  glare and dark adaptation, central and near 
vision, peripheral vision and outdoor mobility respectively(25), similarly in Indonesia 
dark adaptation and glare were strongly correlate with visual field loss(26). 
 
A Nigerian comparative study showed that glaucoma patients QOL were affected by 
POAG even it is mild, also this study reveals those patients who are  women and who 
have high educational status had better VR-QOL (27).but in China there is no QOL 
difference among male and female glaucoma patients (28). 
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                                            Conceptual frame work 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1:- Conceptual framework showing possible associated factors with quality of life 
of patients with glaucoma, university of Gondar hospital eye care and teaching centre, 
Gondar Ethiopia 2015. 
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1.3 Justification of the study 
 
Individuals diagnosed with glaucoma can lose their QOL for several reasons: worry and 
anxiety due to diagnosis of a chronic illness, functional loss, the inconvenience of the 
treatment, side effects, and cost of the therapy(29, 30). 
The main goal of glaucoma treatment is to maintain the patient’s QOL, which includes 
preservation of visual function, at a sustainable cost,(29, 31). So far clinical indicators 
have been used but patients are not interested unless it translates into their QOL 
improvement, therefore measuring QOL implies patients’ ability of day to day activities 
and also patients’ perception becomes central to determine, evaluate and monitor 
treatment outcome. Therefore  evaluation of QOL based on patients subjective 
assessment of their visual function is very useful instrument which helps to decide about 
the ways of treatment(32). 
Though, much has been written on this subject in developed countries, little research 
has been done in developing countries including Ethiopia. 
Therefore, this study was conducted to assess and identify factors associated with 
quality of life among adult glaucoma patients, generate necessary data to support and 
guide for glaucoma management policies, and also provide baseline for further similar 
studies to allow detailed description of unique factors that facilitate or inhibit the quality 
of life in glaucoma patients. 
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2. Objectives 
2.1 General objective 
 
 Quality of life and associated factors among people with glaucoma at university of 
Gondar Hospital, Gondar, Ethiopia 2015. 
2.2 Specific objectives 
 
 To estimate the magnitude of poor quality of life of patients with glaucoma. 
 To identify factors associated with poor quality of life of patients with glaucoma. 
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3.  Methods and materials 
3.1 Design and period 
Institution based cross -sectional study was conducted from April 24 to May 27, 2015. 
3.2 Study area 
The study was conducted at University of Gondar hospital eye care and teaching 
center. It is a referral hospital that serves a total catchment population of about 5 million 
that includes 6 zones of Amhara region and 2 zones from adjacent regions of Tigray 
and Benshangul. Eye care and teaching center of the university hospital is tertiary levels 
that serve for who are living in Gondar administration zone and the neighboring regions. 
It is the only tertiary eye care center for population in the northwest Ethiopia. And it has 
five special clinics (anterior segment, pediatric and strabismus, vitro-retina and 
refraction) among that Glaucoma is the one.  
3.3 Source population  
All adult patients with glaucoma on follow up at UGHECTC. 
3.4 Study population 
All adult patients with glaucoma who are on follow up at UGHECTC who came during 
the study period. 
3.4.1 Inclusion criteria 
Adult patients who were clinically diagnosed with glaucoma in the outpatient department 
of UGHECTC whose age 18 years and above were included in the study. 
 
3.4.2 Exclusion criteria 
Newly diagnosed patients with glaucoma of less than three month were excluded. 
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3.5. Sample size and sampling procedures  
3.5.1 Sample size 
Using single population proportion formula the sample size was calculated   as follows;   
 
 
Where:    n =sample size 
Z (α/2) = Z score at 95% CI=1.96 
P= prevalence of quality of life among glaucoma patient, as prevalence of QOL among        
glaucoma patient is unknown in Ethiopia. = p= 50%. 
 q= 1-p   
 d= margin of error=5%             
=     (1.96) 2.0.5(0.5)  
               (0.05) 2 
=   384  
Since the total population number is less than 10,000, by using correction formula. 
nf = n0/1+no/N 
nf = total sample size 
no= sample size from the above 
N = total population 
nf =  384/ (1+ (384/1113) 
nf =  384/1.345=286            
 
But because of non-respondents and incomplete patient chart, we have to add 10% 
non-response rate. 
n f = no+ 10% = 314.55 
 = 315 
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3.5.2 Sampling technique 
To select 307 patients from a total of 1,113adult patients with confirmed glaucoma that 
were diagnosed by senior glaucoma specialist, all consecutive patients who came to the  
hospital were  included for the study until the required sample were obtained. 
3.6. Study variables 
3.6.1. Dependent variable  
 Quality of life (poor/ good QOL). 
3.6.2. Independent variables 
 Socio–demographic variables such as:- 
 Age 
 Sex 
 Residence  
 Marital status 
 Religion 
 Ethnicity 
 Education 
 Occupation  
 Monthly income  
 Clinical characteristics ;  
 Time of  diagnosis 
 Visual acuity (Snellen VA chart) 
 Stage of glaucoma (based on CD-ratio) 
 Glaucoma diagnosis  
 Laterality  
 Drug Side effects  
 Duration of treatment 
 Presence of other eye diseases  
 Drug adherence 
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3.7. Operational definitions 
 
Good QOL: - individuals who scored less than mean in the Glaucoma Quality of Life 
scale are considered to have good quality of life. 
 
Poor QOL: - individuals who scored greater than or equal to mean in the Glaucoma 
Quality of Life scale are considered to have poor quality of life. 
 
Non adherent:  a person having glaucoma and using anti glaucoma drugs and  
Scoring 3 or more on the 8 item Morisky medication adherence screening tool. 
 
Glaucoma staging: By using better eye  cup to disc ratio (CDR) (33), glaucoma staging 
classified as mild ( ≤0.65 DD), moderate (0.7- 0.85CDD) and sever ( ≥0.9 DD). 
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3.8. Data collection tools and procedures 
Data were collected by using a structured questionnaire consisting socio-demographic 
characteristics, clinical factors of glaucoma, glaucoma quality of life and drug non 
adherence. Face to face interview and patient’s medical chart review were employed to 
obtain the data. 
 Concerning quality of life GQOL-15 contains 15 items and 4 domains of visual function: 
central and near vision (2 items), peripheral vision (6 items), glare and dark adaptation 
(6 items) and outdoor mobility (1item) (34). 
 The internal consistency of the instrument was checked by face validity by one 
glaucoma specialist  and two MPH holders and Cronbach‟s alpha was (0.96),corrected 
item total correlation (0.5 - 0.8) further confirmed good homogeneity of the 
questionnaire. This instrument is reported to have psychometric property as it was 
validated at USA (35), Germany (36) and China (37). 
 Each item of the questionnaire is scored from 0 – 5, 0(abstinence from activity owing to 
non-visual reasons), 1(no difficulty), and 5 (severe difficulty). Summary scores 
represented the sum of item-level response scores with higher scores indicating poorer 
G-QOL.  
Sub-scale was calculated for each factor by averaging the sum of scores generated for 
the item-level responses. Higher subscale scores represented more difficulty with vision 
related activities and poor G-QOL. The mean score of each domain and the total score 
was also calculated since quality of life measures in studies are often presented by 
mean (33).  
Drug non adherence was assessed using the 8 item version of self-reporting 
questionnaire of Morisky medication adherence rating scale (MMARS) (38).  
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3.9. Data quality assurance 
All questionnaires was translated into the local language Amharic and then translated 
back into English by experts and senior ophthalmologist and 5 % (15) of the 
questionnaire was pre-tested in Bahir Dar town at Felege-Hiwot Referral Hospital, two 
days training was given for data collectors and supervisors on the questionnaire to be 
used, the purpose of the study and how to approach respondents and obtain consent.  
Two interviewers (data collectors) were assigned to administer the questionnaire after 
informed consent and the principal investigator and supervisor (optometrist) was 
engaged to review the chart, strictly supervise the data collection process and ensure 
completeness and consistency during and after the data collection process.  
3.10. Data processing and analysis 
The coded Data was checked, cleaned and entered into Epi Info version 7 and was 
exported into SPSS window version 20 for analysis. Frequencies, percentage, mean, 
standard deviation and graphs were used to describe study results.  
Logistic regression model was performed to assess the association between binary 
outcomes and different explanatory variables. Bivariate analysis was first conducted for 
each potentially explanatory variable. Variables that satisfied p-value < 0.2 were 
selected for further analysis using multiple logistic regression model. The strength of 
association was interpreted using odds ratio and confidence interval. P-value < 0.05 
was considered statistically significant in this study. 
3.11. Ethical consideration 
Ethical clearance and approval was obtained from institutional review board of University 
of Gondar, college of medicine and health science ethical review committee. And Official 
letters was obtained from department of optometry. Informed consent was gained from 
participants and they were informed that participation were on voluntary basis and were 
given the right to refuse to take part in the study as well as to withdraw at any time during 
the interview process. No names or identifying information were indicated on the 
questionnaires, and all subjects were assured of confidentiality.  
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4. Results 
4.1. Socio-demographic characteristics of the respondents 
A total of 307 study participants were interviewed giving a response rate of 97.5%. 
Among study participants, 201 (65.5%) were male. The mean age of the respondents 
was 60.33 (SD±14.01) years. Majority of respondents were in between 41and 70 years 
of age group191 (62.2%), 170 (55.4%) of the respondents live in rural setting, 138(45%) 
were unable to read and write,   130(42.3%) were farmers, 216 (70.4%) were married 
and 298 (97.1%) are Amhara, 283 (92.2%) Orthodox, 149(48.5%) had a monthly 
income of <400 ETB (Table 1). 
Table_1.Socio-demographic characteristics of study participants at university of Gondar 
hospital eye care and training center, Gondar, 2015 (N= 307). 
VARIABES CATAGORIES FREQUENCY PERCENTAGE  
Sex Male         
Female             
 201 
106 
65.5 
34.5 
 
Age 
 
 
18-40 
41-70 
>=71                          
   
  42 
 191 
   74 
 
 13.7 
 62.2 
 24.1 
 
Residence Urban 
Rural 
 
137 
170 
44.6 
55.4 
Education                                              Unable to read and write 
Able to read and write 
Primary education 
Secondary and above 
138 
  93 
  29 
  47 
 
45.0 
30.3 
  9.4 
15.3 
Marital 
Status 
Married 
Currently unmarried 
216 
  91 
 
70.4 
29.6 
 
Religion Orthodox 
Muslim/Protestant 
283 
  24 
 
92.2 
  7.8 
 
Occupation 
 
Government Employee 
 Farmer 
House wife  
Dependent on family 
  56 
130 
  65 
  56 
 18.2 
 42.3 
 21.2 
 18.2 
Ethnicity Amhara 
Tigre 
298 
    9 
 
 97.1 
  2.9 
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4.2. Clinical characteristics of the respondents 
Regarding on time of diagnosis 194 (63.2%) were between one and five years, 70 
(22.8%) of the respondents were severely visually impaired, 113(36.8%) respondents 
had sever glaucoma, of all the respondents 279 (90.9%) had bilateral glaucoma, 
164(53.4%) had primary open angle glaucoma followed by 111(36.2%) had 
Pseudoexfoliative glaucoma.  
 
One hundred forty nine (48.5%) had other ocular disease, of these 104(33.9%) was 
cataract, 155(50.5%) had no drug side effects, 156(50.8%) were on treatment for less 
than one year, Two hundred sixty six (73.3%) were non adherent to the drugs (Table2).   
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Table_2:  Clinical characteristics of study participants at university of Gondar hospital 
eye care and teaching center, Gondar, 2015 (n= 307). 
Variables Categories Frequency      Percentage    
 Time of diagnosis < 1 year 
1-5 years 
≥  6 years  
  75 
194 
  38 
 24.4 
 63.2 
 12.4 
Current Visual Acuity  Normal 
Moderate VI 
Sever VI 
 
111 
126 
  70 
 36.2 
 41.0 
 22.8 
Stages of glaucoma  
 
Mild 
Moderate 
Sever  
 126 
   68 
 113 
41 
22.1 
36.8 
Drug side effect No 
Yes 
155 
152 
50.5 
49.5 
Duration of treatment 
 
 
Laterality  
 
< 1 year 
1-5 years 
≥  6 years 
 Bilateral   
 Unilateral                        
156 
130 
  21 
 279 
28
50.8 
 42.3 
  6.8 
 90.9 
   9.1 
Glaucoma type                     
 
 
POAG 
Pseudoexfoliative 
CACG 
164 
111 
  32 
53.4 
36.2 
10.4 
 
Other ocular disease         
 
Yes 
No 
 
149                          
158                           
 
48.5 
51.5 
Drug Adherence 
 
Adherence 
No Adherence 
  82 
225 
 26.7 
 73.3 
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4.3. Glaucoma related quality of life of respondents 
4.3.1. Distribution of overall QOL 
 
In this study 52.8% (95% CI: 47.2 - 58.6%) of Glaucoma patients have poor quality of 
life. 
 
 
 
   
Figure 2: pie chart showing overall quality of life among glaucoma patients attending at 
university of Gondar hospital eye care and teaching centre, Gondar Ethiopia, 2015. 
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4.3.2 Distribution of Domains of QOL  
The GQOL-15 covers four different domains of quality of life, central and near vision, 
outdoor mobility, peripheral vision and (dark adaptation and glare). In the central and 
near vision aspects 45% (95% CI: 39.4 - 49.9%), outdoor mobility 56.7% (95% CI: 51.1 
- 63.1%), peripheral vision 50.5% (95% CI: 44.0 - 56.4%) and dark adaptation and glare 
54.1% (95% CI: 48.9 - 59.6%) of respondents scored above the mean of   each 
subscale (Table 3). 
Table 3 Distribution of four subscales  of GQOL-15 among glaucoma patients at 
university of Gondar eye care and teaching center,  Gondar Ethiopia, 2015 (n=307). 
Variables Mean ±SD Poor QOL 
 Frequency 
Good QOL 
Frequency 
Central and Near 
vision domain 
 
(6.1±2.6) 138(45) 169 (55) 
Outdoor mobility 
domain 
(2.8±1.55) 174(56.7) 133 (43.3) 
Peripheral vision  
domain 
(17.2 ± 7.6) 155(50.5) 152 (49.5)  
 
Dark adaptation 
and Glare domain 
(20.2± 7.09) 166 (54.1) 141 (45.9) 
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4.4. Factors associated with quality of life 
4.4.1 Bivariate analysis  
In the bivariate analysis variables including age, sex, residence, marital status, religion, 
education, occupation, monthly income, time of diagnosis, visual acuity, glaucoma 
stage, glaucoma type and presence of other ocular disease were found to be 
significantly associated with quality of life.  
However, variables such as ethnicity, duration of treatment, laterality, drug side effect 
and drug adherence did not have statistically significant association with quality of life. 
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Table 4: Bivariate and Multivariate analysis of variables with quality of life among 
glaucoma patients at university of Gondar hospital eye care and teaching center, 
Gondar Ethiopia, 2015 (n= 307). 
Variable       Quality of life 
Poor                Good 
COR (95%CI)       AOR (95%CI)  
 
 
Age 
<40 years                                   
41-70 years 
≥ 71 years 
Sex  
Male 
Female  
Residence 
Rural 
Urban 
 
Marital status  
Married 
Currently unmarried  
Religion 
Orthodox 
Muslim/protestant  
Education 
Unable to read and write  
Able to read and write 
Primary school 
Secondary school and 
above  
Ethnicity  
Amhara  
Tigray  
Monthly Income         
< 400  
400-1000 
> 1000 
 
 
8(19) 
107(56) 
47(63.5) 
 
118(58.7) 
44(41.5) 
 
119(70) 
43(31.4) 
 
 
125(57.9) 
37(40.7) 
 
155(54.8) 
7(29.2) 
 
83(60.1) 
64(68.8) 
8(27.6) 
7(14.9) 
 
 
160(53.7) 
    2(22.2) 
 
108(72.5) 
49(44.5) 
5(10.4) 
 
 
 34(81) 
84(44) 
27(36.5) 
 
83(41.3) 
62(58.5) 
 
51(30) 
94(68.6) 
 
 
  91(42.1) 
  54(59.3) 
 
128(45.2) 
17(70.8) 
 
55(39.9) 
29(31.2) 
21(72.4) 
40(85.1) 
 
 
138(46.3) 
    7(77.8) 
 
41(27.5) 
61(55.5) 
43(89.6) 
 
  
1.00 
5.41(2.38-12.31)*** 
7.39(2.99-18.26)***     
 
2.00(1.24-3.23)*** 
1.00 
 
5.10 (3.13-8.30) *** 
1.00      
 
 
2.00 (1.21-3.29)*** 
 1.00 
  
2.94(1.18-7.31)** 
1.00 
 
8.62(3.60-20.63)*** 
12.61(5.05-31.48)*** 
2.17(0.69-6.83) 
1.00 
 
 
4.06(0.83-19.86)* 
1.00 
 
22.65(8.39-61.18)*** 
6.91(2.54-18.77)*** 
1.00 
 
 
1.00 
3.51(1.19-10.28)** 
3.72(1.15-12.02)** 
 
 
 
 
2.16(1.10-4.22) ** 
1.00 
 
 
2.27(1.13-4.56)** 
1.00 
 
 
 
 
 
 
 
 
 
 
 
 
 
10.79(3.36-34.64)*** 
   3.07(0,99-9.48) 
1.00 
Occupation  
Government  employee 
Farmer  
House wife  
Dependent on family  
 
 
 
10(17.9) 
90(69.2) 
30(46.2) 
32(57.1) 
 
 
 
46(82.1) 
40(30.8) 
35(53.8) 
24(42.9) 
 
 
 
1.00 
10.35(4.75-22.55)*** 
3.94(1.70-9.13)** 
6.13(2.58-14.56)*** 
 
 
 
 
 
 
 
 
 
21 
 
Variable Quality of  
 
Poor                 
Life 
 
Good 
COR (95%CI)        
 
AOR (95%CI) 
 
Time of diagnosis 
< 1 year 
1-5 Years 
≥  6 years 
Duration of treatment 
< 1 year 
1-5 years  
≥ 6 years  
Presence of other ocular 
disease  
Yes 
NO 
 Drug side effect 
Yes  
No 
Drug adherence  
Good  
Poor 
 
Type of glaucoma  
POAG 
Pseudoexfoliative 
CACG  
 
 
 
26(34.7) 
121(62.4) 
15(39.5) 
 
79(50.6) 
74(56.9) 
9(42.9) 
 
88(59.1) 
74(46.8) 
77(50.7) 
85(54.8) 
 
42(51.2) 
120(53.3) 
 
75(45.7) 
73(65.8) 
14(43.8) 
 
 
49(65.3) 
73(37.6) 
 23(60.5) 
 
77(49.4) 
56(43.1) 
12(57.1) 
 
 
61(40.9) 
84(53.2) 
 
75(49.3) 
70(45.2) 
 
40(48.8) 
105(46.7) 
 
 
89(54.3) 
38(34.2) 
18(56.2) 
 
 
1.00 
3.12(1.79-5.45) *** 
1.23(0.54-2.75)          
          
1.00 
1.29(0.80-2.05) 
0.73(0.29-1.83) 
 
 
1.64(1.04-2.57)** 
1.00 
 
0.85(0.54-1.32) 
1.00 
 
100 
1.09(0.65-1.80) 
 
 
1.00 
2.28(1.38-3.75)*** 
0.92(0.43-1.98) 
 
 
1.00 
2.57(1.29-5.15)*** 
1.04(0.38-2.84)  
 
Visual Acuity  
Normal  
Moderate visual 
impairment 
Severe visual impairment  
 
 
29(26.1) 
84(66.7) 
49(70) 
 
 
82(26.1) 
42(66.7) 
21(70) 
 
 
1.00 
5.65(3.22-9.92)*** 
6.59(3.39-12.81)*** 
 
 
1.00 
 4.09(2.02-8.34)*** 
 2.88(1.21-6.84)* 
Stage of glaucoma     
Mild  
Moderate 
Sever   
Laterality 
Unilateral  
 Bilateral 
 
49(38.9) 
40(58.8) 
73(64.6) 
 
11(39.3) 
151(54.1) 
 
77(61.1) 
28(41.2) 
40(35.4) 
 
  17(60.7) 
128(45.9) 
 
1.00 
2.24(1.23-4.09)*** 
 2.87(1.69-4.85)*** 
 
1.00 
1.82(0.82-4.03) 
 
1.00 
2.22(1.01-4.86)*** 
2.55(1.21-5.34)** 
 
 
P-value represents variables that have statistically significant association on bivariate analysis. 
P-value  <0.20 *,  P– Value <0.05**, P – value <0.01 *** .  
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4.4.2 Multivariate analysis 
The results of multivariate analysis showed that quality of life was significantly 
associated with age, residence, marital status, monthly income, time of diagnosis, visual 
acuity and stages of glaucoma.  
Respondents whose  age 40 and more  were 4 times more likely to have poor quality of 
life as compared to those less than 40 years, 41-71years  (AOR=3.51,95%CI:1.19-
10.28), >=71(AOR=3.72,95%CI:1.15-12.02).  
Being a rural resident was 2 times more likely to have poorer quality of life as compared 
with urban residents(AOR=2.16, 95%CI: 1.10-4.21). 
Regarding on marital status respondents who were married was 2 times more  likely to 
have poor quality of life as compared to currently who are not married  (AOR=2.27, 
95%CI:1.13- 4.56).  
Regarding monthly income, those who had monthly income of<400 ETB were 11 times 
more likely to have poor quality of life (AOR= 10.79, 95%CI: 3.36-34.64) compared to 
those who had monthly income of above 1000ETB.  
Time of diagnosis was found to be significantly associated with poor quality of life. 
Respondents who had 1-5  years time of diagnosis were about 3 times more likely to be 
affected on their QOL(AOR=2.57, 95%CI: 1.29-5.15) compared to those who had less 
than one year of duration of illness.   
Regarding visual acuity moderately visually impaired respondents were 4 times more 
likely to have poor quality of life (AOR=4.09.40, 95%CI: 2.02- 8.34), while those who 
had severe VI were 3 times more likely to have poor QOL (AOR=2.88, 95%CI: 1.21-
6.83) as compared to those who had normal visual acuity. 
Regarding  glaucoma staging those respondents who had moderate glaucoma were 2 
times more likely to have poor QOL (AOR= 2.22, 95%CI: 1.01-4.86) while those who 
had severe glaucoma 3 times more likely to have poor QOL (AOR=2.56, 95%CI:1.21-
5.34) as compared to those who had mild glaucoma.  
Sex, religion, education, occupation, ethnicity, glaucoma type and other ocular disease 
were not statistically significant with quality of life on multivariate logistic regression 
analysis.   
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Table 5: Bivariate and Multivariate analysis of variables with quality of life among 
glaucoma patients at university of Gondar hospital eye care and teaching center, 
Gondar Ethiopia, 2015 (n= 307). 
Variable       Quality of life 
Poor                Good 
COR (95%CI)       AOR (95%CI)  
 
 
Age 
<40 years                                   
41-70 years 
≥ 71 years 
 
Residence 
Rural 
Urban 
 
Marital status  
Married 
Currently unmarried  
 
Monthly Income         
< 400  
400-1000 
> 1000 
 
 
8(19) 
107(56) 
47(63.5) 
 
 
119(70) 
43(31.4) 
 
 
125(57.9) 
37(40.7) 
 
 
108(72.5) 
49(44.5) 
5(10.4) 
 
 
 34(81) 
84(44) 
27(36.5) 
 
 
51(30) 
94(68.6) 
 
 
  91(42.1) 
  54(59.3) 
 
 
41(27.5) 
61(55.5) 
43(89.6) 
 
  
1.00 
5.41(2.38-12.31)*** 
7.39(2.99-18.26)***     
 
 
5.10 (3.13-8.30) *** 
1.00      
 
 
2.00 (1.21-3.29)** 
 1.00 
  
 
22.65(8.39-61.18)*** 
6.91(2.54-18.77)*** 
1.00 
 
 
1.00 
3.51(1.19-10.28)* 
3.72(1.15-12.02)* 
 
 
2.16(1.10-4.22) * 
1.00 
 
 
2.27(1.13-4.56)* 
1.00 
 
 
10.79(3.36-34.64)*** 
  3.07(0,99-9.48) 
1.00 
 
Time of diagnosis 
< 1 year 
1-5Years 
≥  6 years 
 
 
26(34.7) 
121(62.4) 
15(39.5) 
 
 
 
 
49(65.3) 
73(37.6) 
 23(60.5) 
 
 
 
1.00 
3.12(1.79-5.45) *** 
1.23(0.54-2.75)          
          
 
 
 
1.00 
2.57(1.29-5.15)** 
1.04(0.38-2.84)  
 
Visual Acuity  
Normal  
Moderate visual impairment 
Severe visual impairment  
 
 
29(26.1) 
84(66.7) 
49(70) 
 
 
82(26.1) 
42(66.7) 
21(70) 
 
 
1.00 
5.65(3.22-9.92)*** 
6.59(3.39-12.81)*** 
 
 
1.00 
 4.09(2.02-8.34)*** 
 2.88(1.21-6.84)* 
Stage of glaucoma     
Mild  
Moderate 
Sever   
 
49(38.9) 
40(58.8) 
73(64.6) 
 
77(61.1) 
28(41.2) 
40(35.4) 
 
 
1.00 
2.24(1.23-4.09)** 
 2.87(1.69-4.85)*** 
 
1.00 
2.22(1.01-4.86)* 
2.55(1.21-5.34)* 
 
     
P-value represents variables that have statistically significant association on multivariate analysis: 
 p – value <0.05,* p – value <0.01, ** P – value< 0.001***. 
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5. Discussion  
 
In this study, the GQOL-15 showed that  glaucoma patients had poor quality of life in 
domains: Outdoor mobility 174 (56.7%), Dark adaptation and glare 166 (54.1%) and 
Peripheral vision 155(50.5%) which is  consistent with other study findings(24, 26).In 
line with other study (2, 8) central and near vision only 138 (45%) of respondents had 
poor QOL.  
This may be due to the fact that glaucoma respects central vision as a result of this 
central and near vision may not be affected until late stage of the disease course. 
Similar to other studies (14, 22, 39-41), increasing age were four times more likely to 
have poor QOL. This may be explained as age increases the severity of disease, 
difficulty in caring themselves, lack support and economic dependency. 
 
In this study, patients who live in the rural areas were two times more likely to have poor 
quality of life as compared with urban patients. This may be due to glaucoma patients 
who live in rural areas may not be seek medical attention for early detection and 
diagnosis, seeking care very late after getting advanced in glaucoma stages. Moreover, 
rural patients may have less income, for example, in this study, 67% of rural patients 
have less than 400 ETB.  
 
Regarding  marital status,  respondents who were married was 2 times more  likely to 
have poor quality of life as compared to currently who are not married  (AOR=2.27, 
95%CI:1.13- 4.56). The reason may be due to the higher proportion (78.8%) of married 
respondents in this study were from rural areas who may have less socio-economic 
statuses, in addition to this those married individuals were giving attention to their 
family.  
As expected, respondents with less income (<400 ETB), were 11 times more likely to 
have poor quality of life among glaucoma patients, this implies that patients with poor 
economic status have less likely to have good quality of life. The result could be mainly 
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due to the fact that those with better monthly income can access and afford health 
services which later contribute to improve quality of life.  
Time of diagnosis was found to be significantly associated with poor quality of life. 
Respondents who had 1-5 years time of diagnosis were about 3 times more likely 
affected than patient with less than 1 year. The finding of this study were in line with 
other study(6). This could be mainly due to the fact that drug expense, intensive and 
lifelong follow up might affect their social interaction and overall quality life.  
In contrast to this finding newly diagnosed patients have Poor QOL due to worry about 
likelihood of blindness (35). In this study those who had ≥ 6 years were not significantly 
associated. This might be due to 60.5% of them residing in urban.  
 
Consistent with other studies (14, 15, 18, 30, 34), patients with increasing visual 
impairment was more likely to have poor quality of life in this study. This is may be due 
to the fact that as the visual acuity decreases their daily activities may be compromised 
thereby affecting their social and economic status, leading them to poor life. Moreover, 
as the severity of glaucoma increase, their quality of life was more likely to become poor 
which is consistent with other similar studies ((16, 34, 42, 43).  
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6. Limitations of the study 
 
This study has some limitations. Firstly, the study design was cross-sectional and the 
association between QOL and several variables may not be causal. Secondly, the 
glaucoma classification in this study was based on CDR while other studies used visual 
field measurement may lead inconsistent results with study findings and thirdly self 
report bias regarding glaucoma drug non adherence.   
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7. Conclusion and recommendations 
7.1    Conclusion  
This study indicates that high proportion of patients with glaucoma have poor quality of 
life. Increasing age, rural residence, low monthly income, long time of diagnosis, 
increasing visual impairment and increasing glaucoma severity were significantly 
associated with poor quality of life. Establishing glaucoma screening program at 
community level for early detection and treatment, increasing income, special attention 
for those severely  visually impaired, who have sever glaucoma , rural dwellers and 
elders are important factors for improving the quality of life of patients with glaucoma. 
7.2 Recommendations  
 To  ministry of health and other NGOS’ 
Establishing glaucoma screening program at community level for early detection and 
treatment, rehabilitation center for those who have severe visual impairment and severe 
glaucoma and increasing income might be helpful. 
 To clinicians 
Provide health education and  special attention for those severely  visually impaired, 
who have sever glaucoma , rural dwellers and elders are important factors for improving 
the quality of life of patients with glaucoma. 
 To researchers  
Further study is needed on this study area. 
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9. Annexes 
9.1 Consent form 
Patients Information sheet                                              Code No: ------------------- 
Dear participants. 
My name is Banchamelak Zeraye; the University of Gondar undertaking a Masters 
degree in clinical optometry.  Conducting a study on title on quality of life and 
associated factors among glaucoma patients as partial fulfillment of MSc in clinical 
optometry. This questionnaire prepared to collect data to assess the quality of life and 
associated factors among glaucoma patients. The aim of the study is to assess quality 
of life and associated factors among glaucoma patients. If you agree to be included in 
the study, I would like to ask you to sign on a document to show your agreement; 
participate in the interview and answer the questions accordingly your participation is 
completely voluntary, and you can refuse to participate or stop and withdraw from the 
study at any time. Refusal to participate will not result in loss of medical care provided 
or any other benefits. The information in your records is strictly confidential. 
Do you agree? I have listened to the description of the study and I understand. I agree 
to participate in it. 
 
 
                                                                          Signature ---------------------------------------    
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9.2. Data collection instruments 
This questionnaire is designed to assess quality of life and associated factors among 
glaucoma patients at university of Gondar Hospital, department of ophthalmology, 
Gondar. Based on the results, possible suggestion will be given to clinicians to provide 
efficient and sustainable management. All the respondents are kindly requested to 
respond all the questions honestly. Remember your name is not recorded and no one 
will be able to find out who respond this questionnaire 
The questionnaire has four parts. It will take about 30 minutes to complete the interview. 
Please try to respond all questions. Thank you very much for your patience. 
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Part :I  
Socio-demographic characteristics 
 
S.no 
 
Questions 
 
 Response and coding 
 
101 
 
Age in year 
 
------------------------------- 
 
 102 Sex 1. Male                                 2. Female 
 103 Residence 1. Urban                               2. Rural 
 
104 
 
Marital status 
1. Married                              3.  Divorced 
2. Single                            4. Widowed 
 
 105 
 
Religion 
1. Orthodox                 4. Catholic 
      2. Muslim                     5Others 
      3. Protestant(specify)__________________ 
 
106 
 
Educational status 
1.unable to read and write 
2. Read and write only  
3._____grade  
 
107 
 
Occupation 
1.  Employs               4. House wife                                                         
2. Merchant            5. Day labor  
3 Farmer.                 6.None/dependent on family 
                                 7.Others (specify)------------------- 
 
 108 
 
Ethnicity 
     1. Amhara                   3.Oromo 
2. Tigre4. Others (specify)------------ 
 
 
109 
 
Monthly income in birr 
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Part II 
Clinical characteristics   
201  
Time of diagnosis               
 
         --------------------- 
202  
Current visual acuity                            
 
 
OD     ___________ OS     --------------------     
 
203 Stages of glaucoma based on CD 
Ratio :         
 
OD  1.Mild  
        2.Moderate  
        3.Advanced  
        4. absolute  
        5. no 
 
OS  1.Mild  
        2.Moderate  
        3.Advanced  
        4. absolute  
        5. no 
 
204 Drug side effect  1. None                         3. Burning sensation 
2. Dryness                     4. Redness                                                                             
5. Others----------------------- 
205 Duration of treatment     
 
1. Less than 1 year               2.   1 – 5 years 
3.6 – 10 years             4. Greater than 10 Years 
206 Glaucoma diagnosis      
 
 
1.  Primary open-angle        3.  Chronic angle                   
     closure 
 
2.    Exfoliation                      4.   Other 
 
207 Presence of other eye diseases      1. Corneal diseases      3. Vascular diseases      
2. Cataract                    4.Macular diseases  
5. other specify             6.no  
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Part III 
Glaucoma related Quality of Life (GQL-15) questionnaire 
0 = Abstinence from activity owing to non-visual reasons 
1 = No difficulty                                  3   =   Some difficulty,       5=  Severe difficulty 
2 = A little bit of difficulty,                4   =  Quite a lot of difficult, 
 Glaucoma relates quality of life (GQL-15) 0 1 2 3 4 5 
301 Reading  newspapers , sewing, hand craft  0 1 2 3 4 5 
302 Walking after dark  0 1 2 3 4 5 
303 Seeing at night  0 1 2 3 4 5 
304 Walking on uneven road  
 
0 1 2 3 4 5 
305 Adjusting to bright lights  
 
0 1 2 3 4 5 
306 Adjusting to dim lights  
 
0 1 2 3 4 5 
307 Going from dark room and vice versa  
 
0 1 2 3 4 5 
308 Tripping over objects  
 
0 1 2 3 4 5 
309 Seeing objects coming from side  
 
0 1 2 3 4 5 
310 Crossing the road  
 
0 1 2 3 4 5 
311 Walking on steps/stairs  
 
0 1 2 3 4 5 
312 Bumping into objects  
 
0 1 2 3 4 5 
313 Judging distance of foot to step/surb 
 
0 1 2 3 4 5 
314 Finding dropped objects  
 
0 1 2 3 4 5 
315 Recognizing faces.  0 1 2 3 4 5 
 
36 
 
PART VI Drug non adherence measurement 
Morisky 8-Item Medication Adherence Questionnaire 
 
401. 
 
Do you sometimes forget to take your medicine? 
No=0 Yes=
1 
 
402. People sometimes miss taking their medicines for 
reasons other than forgetting. Thinking over the past 
2 weeks, were there any days when you did not take 
your medicine? 
No=0 Yes=
1 
403. Have you ever cut back or stopped taking your 
medicine without telling your doctor because you felt 
worse when you took it? 
No=0 Yes=
1 
404. 
 
 
When you travel or leave home, do you sometimes  
forget to bring along your medicine? 
No=0 Yes=
1 
405. Did you take all your medicines yesterday? 
 
No=0 Yes=
1 
406. When you feel under control, do you sometimes stop 
taking your medicine? 
No=0 Yes=
1 
407. Taking medicine every day is a real inconvenience 
for some people. Do you ever feel hassled about 
sticking to your treatment plan? 
No=0 Yes=
1 
408. How often do you have difficulty remembering to 
take all your medicine? 
__ A. Never/rarely 
__ B. Once in a while 
__ C. Sometimes 
__ D. Usually 
__ E. All the time 
No=0 Yes=
1 
Name and signature of data collector ----------------------Signature-----------------Date---------
Name and signature of supervisor----------------------- Signature-----------------Date------------ 
 
 
                                                                                                                Thank you 
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የታካሚው መረጃ ቅጽ እና ተሳትፎ ማረጋገጫ መሇያ ቁጥር ------------ 
የታካሚው መረጃ 
ውዴ ተሳታፉዎች 
ስሜ ባንችአምሊክ ዘርአይ ይባሊሌ፡፡በጎንዯር ዩኒቨርሲቲ ሆስፒታሌ የዴህረ ምረቃ ተማሪ ነኝ፡፡ 
የማጠናዉ ጥናት ከአይን ግፉት በሽታ ጋር የሚኖሩ ሰዎች የሚገጥማቸውን የህይወት የአኗኗር 
ጥራት ዯረጃ እና መንስኤዎቹን የክሉኒካሌ ኦፕቶሜትሪ ህክምና በከፉሌ ሇሁሇተኛ ዴግሪ 
ማሟያ ነዉ፡፡  
ይህ መጠይቅ የተዘጋጀዉ ከአይን ግፉት በሽታ ጋር የሚኖሩ ሰዎች የሚገጥማቸውን የህይወት 
አኗኗር የጥራት ዯረጃ እና መንስኤዎቹ ሊይ መረጃ ሇመሰብሰብ ነዉ፡፡የዚህ ጥናት ዓሊማ 
በዉጤቱ መሰረት  ከአይን ግፉት በሽታ ችግር ጋር ከአኗኗር  ሁኔታ መዛባት ጋር ያሇዉን 
ተዛማጅነት ሇማጥናት ነዉ፡፡በዚህ ጥናት ሊይ ሇመሳተፍ ከፇሇጉ የስምምነት ፉርማዎትን በቅፁ 
ሊይ መፇረም ይኖርብዎታሌ፡፡ ከዚያም በመረጃ ሰብሳቢዎቹ ምሊሽዎን እንዱሰጡ ይጠየቃለ፡፡ 
የርሰዎ ተሳትፎ በሙለ በፍቃዯኝነት ሊይ የተመሰረተ ነዉ ፡፡መሳተፍ ባሌፇሇጉ ጊዜ 
ሊሇመሳተፍ መወሰን የሚችለ ሲሆን የሚፇሌጉትን የጤና አገሌግልት ከማግኘት 
አይገዴበዎትም፡፡ ሇእርስዎ ካሌመሰሇዎት ከዚህ ጥናት ተሳታፉነት በማንኛዉም ጊዜ ራስዎን 
የማግሇሌ ሙለ መብት አሇዎት፡፡ መጠይቁ በጥናቱ ስሇሚካተቱ ግሇሰቦች ስምና መሇያ 
አይጻፍበትም፡፡ የሚገኘው መረጃም በሚስጥር የሚያዝ ሲሆን ግኝቱ ምበጥቅሌ የሚቀርብ 
ይሆናሌ፡፡ 
ሇመሳተፍ ፇቃዯኛነዎት?        አዎ                              አይዯሇሁም 
 
ፉርማ ----------------------------- 
መጠይቅ 
ይህ መጠይቅ የተዘጋጀዉ በጎንዯር ዩኒቨርስቲ ሆስፒታሌ የአይን ህክምና ክፍሌ ክትትሌ ሊይ 
ያለ ከአይን ግፉት በሽታ ጋር የሚኖሩ ሰዎች የሚገጥማቸውን የህይወት አኗኗር የጥራት 
ዯረጃ እናመንስኤዎቹ ሊይ መረጃ ሇመሰብሰብ ነዉ፡፡በጥናቱ ዉጤት መሰረት ሇህክምና 
ሞያተኞች ትክክሇኛ እና ቋሚ ሀሳቦችን ይሰጣሌ፡፡ሁለም የመጠይቅ ተሳታፉዎች ጥያቄዎቹን 
በታማኝነት እንዱመሌሱ በትህትና እንጠይቃሇን፡፡ አስታዉሱ፡-ስም መፃፍ አያስፇሌግም 
እንዴሁም ማንም ሰዉ የተሞሊዉን መጠይቅ ማን እንዯሞሊዉ ማወቅ አይችሌም፡፡ 
መጠይቁ አራት ክፍሌ አሇው፡፡ ቃሇ መጠይቁን ሇማጠናቀቅ 20 ዯቂቃ የሚፇጅ ሲሆን ሁለንም 
ጥያቄዎች ሇመመሇስ ይሞክሩ፡፡ሇትእግስትዎ እናሰመግናሇን፡፡ 
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ክፍሌ I ማህበራዊመረጃዎች 
ተ.ቀ መጠይቅ  ምርጫ 
101 እዴሜ ስንት ነው 
 
 
----------------------------- 
102 
 
ፆታ   1.ወንዴ2..ሴት 
103 የመኖሪያ ቦታ   1. ከተማ2..ገጠር 
104 
 
 
የጋብቻ ሁኔታዎ 
1. ያገባ/ች               3.የፇታ/ች   
2. ያሊገባ/ች            4. የሞተበት/ባት         
 
105 
 
 
ሀይማኖትዎ ምንዴን ነው 
 
1. ኦርቶድክስ           4. ካቶሉክ 
2. ሙስሉም     5. ላሊ ካሇ ይገሇፅ ------- 
3. ፕሮቴስታንት 
106 የትምህርት ዯረጃ 1. ማንበብ እና መጻፍየሚችሌ 
2. ማንበብና መጻፍ ብቻ የማይችሌ 
3.  _____   ክፍሌ ይገሇጽ 
107 ስራዎ ምንዴን ነው 1. የመንግስት ሰራተኛ      4. የቤት እመቤት 
2. ነጋዳ                 5. የቀን ሰራተኛ 
3. ግብርና                6. የሇም በቤተሰብስር        
7. ላሊ ካሇ----------- 
108 ብሔርዎ  ምንዴን ነው 1. አማራ                3. ኦሮሞ 
2. ትግሬ              4.  ላሊ ካሇ ይገሇፅ ---- 
109 ወርሃዊ ገቢዎ ምን ያህሌ 
ብር ነው 
------------------------------ 
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ክፍሌ II ህመምመረጃ 
ተ.ቀ መጠይቅ ምርጫ 
201 የአይን ግፉትበሽታ ካመመዎት 
(ካወቁት) ምን ያህሌ ጊዜ 
ይሆናሌ 
 
------------------------- 
 
202 
 
አሁን ያሇዉ የእይታ ሁኔታ 
 
የቀኝአይን    ---------   የግራአይን    -------- 
203 የአይን ግፉት በሽታ ዯረጃ ፡ የቀኝአይን 
1. ማይልድ 
2. ሞዯሬት 
3. አዴቫንስዴ 
4. አብሶለት 
5. የሇም 
የግራአይን 
1. ማይሌዴ 
2. ሞዯሬት 
3. አዴቫንስዴ 
4. አብሶለት 
5. የሇም 
204 የመዴሀኒት የጎንዮሽ ጉዲት 1. ምንም የሇም           3.  የአይን ማቃጠሌ ስሚት 
2. የአይን ዴርቀት ስሜት  4.  የአይን መቅሊት 
5. ላሊ______
205 ሇምን ያህሌ ጊዜ 
መዴሃኒተዎን ወሰደ 
1. 1 ዓመትበታች2. 1–5 ዓመት 
3.6-10 አመት4. ከ10 ዓመት በሊይ 
206 የአይን ግፉት በሽታ አይነት 1.ፕራይመሪ ኦፕንአንግሌ ግሊኮማ 
2. ሲድኤክስፎላቲቭ ግሊኮማ 
3.ክሮኒክአንግሌክልዠር ግሊኮማ 
4.ላሊ  ----------------------- 
207 ላሊ የአይን በሽታ አሇ 1. የአይን ብላን ህመም             3.  ቫስኩሇር ዱዝዝ 
2. የአይን ሞራ                    4.  ማኩሊር ዱዝዝ 
5.ላሊ ካሇ ይገሇፅ----------------        6.  የሇም 
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ክፍሌ III ከአይን ግፉት በሽታ ጋር የህይወት አኗኗር የጥራት ዯረጃ  መሇኪያ መጠይቅ 
   0 =  በእይታ ችግር ባሌሆነ ምክንያት ስራ መስራት አሇመቻሌ 
1 =  ምንም ችግር የሇም                  4 =  በጣም ችግር አሇ 
2 =  ትንሽ ችግር አሇ 
3 =  መጠነኛ ችግር አሇ                   5 =እጅግ በጣም ችግር አሇ 
ተ.ቀ ከአይን ግፉት በሽታ ጋር የህይወት አኗኗር የጥራት ዯረጃ  
መሇኪያ 
0 1 2 3 4 5 
301 ጋዜጣ ማንበብ ፣  እህሌ መሌቀም፣የእጅ ስራ፤ እሾህ 
ማዉጣት ፤ የተንቀሳቃሽ ስሌክ ቁጥር መሇየት፤ የፀልት 
መጸኃፍ ማንብበብ /ቁርአን መቅራት 
0 1 2 3 4 5 
302 በጨሇማ የግር ጉዞ ማዴረግ 0 1 2 3 4 5 
303 በጨሇማ ጊዚ እይታ 0 1 2 3 4 5 
304 ባሌተስተካከሇ (ወጣ ገባ በሆነ) መንገዴ የግር ጉዞ ማዴረግ 0 1 2 3 4 5 
305 በዯመቀ ብርሃን (በፀሐይ ጮራ) የማየት ችልታ 0 1 2 3 4 5 
306 በዯበዘዘ ብርሃን (ዴግዝግዝ ሲሌ) የማየት ቸልታ 0 1 2 3 4 5 
307 ከጨሇማ ክፍሌ ወዯ ብርሀን /ከብርሀን ወዯ ጨሇማ ክፍሌ 
በግር ጉዞ ማዴረግ 
0 1 2 3 4 5 
308 መዯናቀፍ 0 1 2 3 4 5 
309 በጎን የሚመጡ ነገሮችን መሇየት 0 1 2 3 4 5 
310 መንገዴ ማቋረጥ መቻሌ 0 1 2 3 4 5 
311 ዯረጃ(ዲገት እና ቁሌቁሇት) መዉጣት እና መዉረዴ መቻሌ 0 1 2 3 4 5 
312 ከእቃ / ከግዴግዲ / ከዛፍ / ከበርጋርመጋጨት 0 1 2 3 4 5 
313 እግር ከምዴር ጋር ያሌዉን ርቀት መገምት መቻሌ 0 1 2 3 4 5 
314 የወዯቀ እቃን ሇይቶ ማንሳት 0 1 2 3 4 5 
315 የሰዉ መሌክ መሇየት መቻሌ 0 1 2 3 4 5 
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ክፍሌ IV 
በሀኪም ትዕዛዝ መሰረት የመዴሀኒት አጠቃቀም መሇኪያ በህመምተኛው የሚሞሊ የሞርስኪ 
ባሇስምንት መጠይቅ 
ተ.ቁ  ጥያቄዎች አሊውቅም=0 አዎ=1 
401 መዴሃኒትዎን መውሰዴ ረስተው/ዘንግተው ያውቃለ? አሊውቅም=0 አዎ=1 
403 ከመርሳት ውጭ  ሰዎች በላሊ ምክንያት አንዲንዳ መዴሐኒታቸውን ሳይወስደ 
ይቀራለ።እርስዎ ባሇፈት ሁሇት ሳምንታት መዴሐኒትዎን ያሌወሰደባቸው 
ቀናት አለ? 
አሊውቅም=0 አዎ=1 
404 መዴሐኒትዎን ሲወስደ ሕመሙ የባሰብዎት ስሇመሰሇዎት 
ሐኪምዎን ሳያማክሩ መዴሐኒት አቋርጠው ያውቃለ? 
አሊውቅም=0 አዎ=1 
405 መንገዴ ሲጓዙ ወይም ከቤት በሚወጡበት ጊዜ አንዲንዳ መዴሐኒትዎን ሇመያዝ 
ረስተው/ዘንግተው ያውቃለ?  
አሊውቅም=0 አዎ=1 
406 ሁለንም መዴሐኒትዎትን  ትሊንት ወስዯዋሌ? አሊውቅም=0 አዎ=1 
407 የህመምዎ  ምሌክቶች (ህመምዎ) በቁጥጥር ውስጥ የሆነ በመሰሇዎት 
ጊዜ፤አንዲንዳ  መዴሐኒት መውሰዴን አቋርጠው ያውቃለ? 
አሊውቅም=0 አዎ=1 
408 ቀን በቀን በተከታታይ መዴሐኒት መውሰዴ ሇአንዲንዴ ሰዎች 
ያስቸግራቸዋሌ።አርስዎ በአግባቡ መዴሐኒትዎን በመውሰዴዎ (የሕክምና 
መርሐ-ግብርዎን በመከታተሌዎ) ተቸግረው ያውቃለ? 
አሊውቅም=0 አዎ=1 
409 
 
 
ምን ያህሌ ጊዜ አስታውሰው ሁለንም መዴሐኒትዎን ሇመውሰዴ 
ተቸግረው ያውቃለ? 
1. በጭራሽ                              4. አሌፎአሌፎ    
2. በአጋጣሚ አንዲንዳ 
3. አንዲንዳ                              5. ሁሌጊዜ 
አሊውቅም=0 አዎ=1 
 
ስሇ ግምገማው አስተያየት ካሇዎት?      
የመረጃ ሰብሳቢ ስም እና ፉርማ ______________________   ቀን __________ 
የሱፐርቫይዘር ስም እና ፉርማ  _______________________  ቀን __________ 
በጣም አመሰግናሇሁ!!! 
ላሊ አስያየት ከሇዎት------------------------------------------------------ 
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